Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval
Go back to Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval| (NASDAQ: LEXX) | Delayed: 12.20 +0.69 (5.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.51 | 52 Week High | $ | |||
| Open | $11.96 | 52 Week Low | $ | |||
| Day High | $12.89 | P/E | N/A | |||
| Day Low | $11.77 | EPS | $ | |||
| Volume | 22,518 | |||||
| (NASDAQ: LEXXW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 1,870 | |||||
